Your browser doesn't support javascript.
loading
EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer.
Amodio, Vito; Yaeger, Rona; Arcella, Pamela; Cancelliere, Carlotta; Lamba, Simona; Lorenzato, Annalisa; Arena, Sabrina; Montone, Monica; Mussolin, Benedetta; Bian, Yu; Whaley, Adele; Pinnelli, Marika; Murciano-Goroff, Yonina R; Vakiani, Efsevia; Valeri, Nicola; Liao, Wei-Li; Bhalkikar, Anuja; Thyparambil, Sheeno; Zhao, Hui-Yong; de Stanchina, Elisa; Marsoni, Silvia; Siena, Salvatore; Bertotti, Andrea; Trusolino, Livio; Li, Bob T; Rosen, Neal; Di Nicolantonio, Federica; Bardelli, Alberto; Misale, Sandra.
Afiliação
  • Amodio V; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Torino, Italy.
  • Yaeger R; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Arcella P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cancelliere C; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Torino, Italy.
  • Lamba S; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Lorenzato A; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Torino, Italy.
  • Arena S; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Torino, Italy.
  • Montone M; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Torino, Italy.
  • Mussolin B; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Bian Y; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Torino, Italy.
  • Whaley A; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Pinnelli M; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Torino, Italy.
  • Murciano-Goroff YR; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Torino, Italy.
  • Vakiani E; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Valeri N; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Liao WL; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Torino, Italy.
  • Bhalkikar A; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Thyparambil S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zhao HY; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • de Stanchina E; Center for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
  • Marsoni S; Department of Medicine, The Royal Marsden Hospital, London, United Kingdom.
  • Siena S; mProbe Inc., Rockville, Maryland.
  • Bertotti A; mProbe Inc., Rockville, Maryland.
  • Trusolino L; mProbe Inc., Rockville, Maryland.
  • Li BT; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rosen N; Antitumour Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Di Nicolantonio F; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Bardelli A; Antitumour Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Misale S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Cancer Discov ; 10(8): 1129-1139, 2020 08.
Article em En | MEDLINE | ID: mdl-32430388
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article